506260 — Anuh Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹12.81bn
- IN₹12.32bn
- IN₹5.27bn
- 84
- 21
- 97
- 81
Annual cashflow statement for Anuh Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 324 | 192 | 386 | 391 | 475 |
| Depreciation | |||||
| Non-Cash Items | -38.4 | 12.7 | -76.5 | -37.9 | -53.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -231 | 215 | -647 | -184 | 20.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 71.2 | 489 | -187 | 289 | 539 |
| Capital Expenditures | -289 | -356 | -61.5 | -16.1 | -15.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 318 | -409 | 584 | -62 | -419 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 28.6 | -765 | 522 | -78.2 | -435 |
| Financing Cash Flow Items | -1.56 | -5.65 | -16 | -10.7 | -1.2 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -65.1 | 222 | -331 | -194 | -123 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 34.7 | -54.3 | 3.53 | 16 | -18.7 |